113 related articles for article (PubMed ID: 17328537)
1. Pharmacophore mapping of selective binding affinity of estrogen modulators through classical and space modeling approaches: exploration of bridged-cyclic compounds with diarylethylene linkage.
Mukherjee S; Nagar S; Mullick S; Mukherjee A; Saha A
J Chem Inf Model; 2007; 47(2):475-87. PubMed ID: 17328537
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore mapping of arylbenzothiophene derivatives for MCF cell inhibition using classical and 3D space modeling approaches.
Mukherjee S; Nagar S; Mullick S; Mukherjee A; Saha A
J Mol Graph Model; 2008 Jan; 26(5):884-92. PubMed ID: 17643328
[TBL] [Abstract][Full Text] [Related]
3. Molecular structural characteristics as determinants of estrogen receptor selectivity.
Agatonovic-Kustrin S; Turner JV; Glass BD
J Pharm Biomed Anal; 2008 Sep; 48(2):369-75. PubMed ID: 18511229
[TBL] [Abstract][Full Text] [Related]
4. Molecular mapping of heterocyclic diazene derivatives for estrogen receptor modulation.
Islam MA; Mukherjee A; Saha A
Indian J Biochem Biophys; 2012 Aug; 49(4):236-45. PubMed ID: 23077784
[TBL] [Abstract][Full Text] [Related]
5. Bridged androstenediol analogs as ER-beta selective SERMs.
Blizzard TA; Gude C; Chan W; Birzin ET; Mojena M; Tudela C; Chen F; Knecht K; Su Q; Kraker B; Holmes MA; Rohrer SP; Hammond ML
Bioorg Med Chem Lett; 2007 May; 17(10):2944-8. PubMed ID: 17448656
[TBL] [Abstract][Full Text] [Related]
6. A molecular docking study of estrogenically active compounds with 1,2-diarylethane and 1,2-diarylethene pharmacophores.
Kekenes-Huskey PM; Muegge I; von Rauch M; Gust R; Knapp EW
Bioorg Med Chem; 2004 Dec; 12(24):6527-37. PubMed ID: 15556769
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore search for anti-fertility and estrogenic potencies of estrogen analogs.
Alam SM; Pal R; Nagar S; Islam MA; Saha A
J Mol Model; 2008 Nov; 14(11):1071-82. PubMed ID: 18663492
[TBL] [Abstract][Full Text] [Related]
8. 3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists.
Wei J; Wang S; Gao S; Dai X; Gao Q
J Chem Inf Model; 2007; 47(2):613-25. PubMed ID: 17330954
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationships for estrogen receptor binding affinity of phenolic chemicals.
Hu JY; Aizawa T
Water Res; 2003 Mar; 37(6):1213-22. PubMed ID: 12598185
[TBL] [Abstract][Full Text] [Related]
10. Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity.
Salum LB; Polikarpov I; Andricopulo AD
J Chem Inf Model; 2008 Nov; 48(11):2243-53. PubMed ID: 18937440
[TBL] [Abstract][Full Text] [Related]
11. Chemical function based pharmacophore generation of endothelin-A selective receptor antagonists.
Funk OF; Kettmann V; Drimal J; Langer T
J Med Chem; 2004 May; 47(11):2750-60. PubMed ID: 15139753
[TBL] [Abstract][Full Text] [Related]
12. Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor.
Vedani A; Dobler M; Lill MA
J Med Chem; 2005 Jun; 48(11):3700-3. PubMed ID: 15916421
[TBL] [Abstract][Full Text] [Related]
13. Quantitative structure activity relationship and pharmacophore studies of adenosine receptor A2B inhibitors.
Joseph TB; Suneel Kumar BV; Santhosh B; Kriti S; Pramod AB; Ravikumar M; Kishore M
Chem Biol Drug Des; 2008 Nov; 72(5):395-408. PubMed ID: 19012575
[TBL] [Abstract][Full Text] [Related]
14. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
Salum Lde B; Polikarpov I; Andricopulo AD
J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
[TBL] [Abstract][Full Text] [Related]
15. In silico identification of bioisosteric functional groups.
Ertl P
Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
[TBL] [Abstract][Full Text] [Related]
16. Computational modeling of biologically active molecules using NMR spectra.
Beger RD
Drug Discov Today; 2006 May; 11(9-10):429-35. PubMed ID: 16635805
[TBL] [Abstract][Full Text] [Related]
17. QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes.
Tong W; Perkins R; Xing L; Welsh WJ; Sheehan DM
Endocrinology; 1997 Sep; 138(9):4022-5. PubMed ID: 9275094
[TBL] [Abstract][Full Text] [Related]
18. Electrophilicity index as a possible descriptor of biological activity.
Parthasarathi R; Subramanian V; Roy DR; Chattaraj PK
Bioorg Med Chem; 2004 Nov; 12(21):5533-43. PubMed ID: 15465330
[TBL] [Abstract][Full Text] [Related]
19. Use of computational modeling approaches in studying the binding interactions of compounds with human estrogen receptors.
Wang P; Dang L; Zhu BT
Steroids; 2016 Jan; 105():26-41. PubMed ID: 26639429
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.
Zampieri D; Mamolo MG; Laurini E; Florio C; Zanette C; Fermeglia M; Posocco P; Paneni MS; Pricl S; Vio L
J Med Chem; 2009 Sep; 52(17):5380-93. PubMed ID: 19673530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
